[go: up one dir, main page]

DE60025704D1 - Das goodpasture-antigen bindende protein - Google Patents

Das goodpasture-antigen bindende protein

Info

Publication number
DE60025704D1
DE60025704D1 DE60025704T DE60025704T DE60025704D1 DE 60025704 D1 DE60025704 D1 DE 60025704D1 DE 60025704 T DE60025704 T DE 60025704T DE 60025704 T DE60025704 T DE 60025704T DE 60025704 D1 DE60025704 D1 DE 60025704D1
Authority
DE
Germany
Prior art keywords
antigen binding
binding protein
gpbp
goodpasture antigen
goodpasture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025704T
Other languages
English (en)
Other versions
DE60025704T2 (de
Inventor
Juan Saus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22397008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60025704(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60025704D1 publication Critical patent/DE60025704D1/de
Publication of DE60025704T2 publication Critical patent/DE60025704T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01037—Protein kinase (2.7.1.37)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60025704T 1999-02-24 2000-02-24 Das goodpasture-antigen bindende protein Expired - Lifetime DE60025704T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12148399P 1999-02-24 1999-02-24
US121483P 1999-02-24
PCT/IB2000/000324 WO2000050607A2 (en) 1999-02-24 2000-02-24 Goodpasture antigen binding protein

Publications (2)

Publication Number Publication Date
DE60025704D1 true DE60025704D1 (de) 2006-04-13
DE60025704T2 DE60025704T2 (de) 2006-09-07

Family

ID=22397008

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025704T Expired - Lifetime DE60025704T2 (de) 1999-02-24 2000-02-24 Das goodpasture-antigen bindende protein

Country Status (10)

Country Link
US (5) US6579969B1 (de)
EP (1) EP1144650B1 (de)
JP (1) JP3761784B2 (de)
AT (1) ATE316577T1 (de)
AU (1) AU760197B2 (de)
CA (1) CA2361987C (de)
DE (1) DE60025704T2 (de)
ES (1) ES2254151T3 (de)
MX (1) MXPA01008605A (de)
WO (1) WO2000050607A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060459B2 (en) 2000-12-08 2006-06-13 Juan Saus TNF-inducible promoters and methods for using
US6881547B1 (en) 2001-01-31 2005-04-19 Juan Saus Methods and reagents for treating autoimmune disorders
US7147855B2 (en) 2001-12-07 2006-12-12 Juan Saus GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
US7326768B2 (en) * 2003-02-05 2008-02-05 Juan Saus Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
JP2005035926A (ja) * 2003-07-14 2005-02-10 Japan Science & Technology Agency セラミド輸送を促進する薬剤、該薬剤を製造する塩基配列、セラミド遊離を促進する活性の測定方法、及びセラミドの膜間移動を促進する活性の測定方法
WO2008107388A1 (en) * 2007-03-02 2008-09-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Improvement of protein production
EP2236285B2 (de) 2007-12-17 2019-05-08 Kureha Corporation Wärmeschrumpfende laminatfolie zum tiefziehen, verpackter artikel und verfahren zur verpackung von käse
WO2010009856A2 (en) * 2008-07-22 2010-01-28 Juan Saus Goodpasture antigen binding protein and its detection
EP2427557B1 (de) 2009-05-05 2015-03-18 Boehringer Ingelheim International GmbH Cho/cert-zelllinien
CN102781898B (zh) * 2009-11-05 2014-12-24 菲布他丁有限合伙公司 使用q2拟肽的gpbp抑制
AU2012219582A1 (en) 2011-02-21 2013-08-22 Fibrostatin S.L. Methods for treating and diagnosing disease
US9066938B2 (en) 2012-07-02 2015-06-30 Fibrostein, S.L. GPBP-1 inhibition and its therapeutic use
US20160184274A1 (en) 2014-12-31 2016-06-30 Fibrostatin, S.L. Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424408A (en) 1990-11-30 1995-06-13 Yale University α-3 chain type IV collagen polynucleotides
US6007980A (en) 1990-11-30 1999-12-28 Yale University Alpha-3 chain type IV collagen polypeptides
US5843646A (en) * 1992-02-17 1998-12-01 Howard Florey Institute Of Experimental Physiology And Medicine DNA molecules encoding murine son of sevenless (mSOS) gene and mSOS polypeptides
US5716622A (en) * 1995-01-06 1998-02-10 The Rockefeller University Functionally active regions of signal transducer and activators of transcription
JP2001507563A (ja) * 1995-11-23 2001-06-12 キャンサー リサーチ キャンペーン テクノロジー リミテッド Ｂｒｃａ２癌感受性遺伝子の同定及び配列決定に関する材料及び方法並びにそれらの使用

Also Published As

Publication number Publication date
JP3761784B2 (ja) 2006-03-29
DE60025704T2 (de) 2006-09-07
US20030054488A1 (en) 2003-03-20
AU760197B2 (en) 2003-05-08
WO2000050607A2 (en) 2000-08-31
WO2000050607A3 (en) 2000-11-30
ATE316577T1 (de) 2006-02-15
JP2003525023A (ja) 2003-08-26
US20100247553A1 (en) 2010-09-30
AU3314000A (en) 2000-09-14
US7189517B2 (en) 2007-03-13
US20030049791A1 (en) 2003-03-13
US7629132B2 (en) 2009-12-08
MXPA01008605A (es) 2003-06-24
ES2254151T3 (es) 2006-06-16
US6579969B1 (en) 2003-06-17
CA2361987C (en) 2007-07-03
EP1144650B1 (de) 2006-01-25
US20070178540A1 (en) 2007-08-02
CA2361987A1 (en) 2000-08-31
EP1144650A2 (de) 2001-10-17
US7186527B2 (en) 2007-03-06

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
EP1187591A4 (de) Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
DK1093517T3 (da) Neisseria-meningitidis-antigener og præparater
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
TR199701462T1 (xx) DNA Dizisi ve bununla kodlanm�� meme'ye �zel g���s kanseri proteini.
BRPI0411854A (pt) veìculos protéicos para vacinas
DK1131444T3 (da) Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse
DE60025704D1 (de) Das goodpasture-antigen bindende protein
UA84284C2 (ru) Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
AU8727201A (en) Genes involved in intestinal inflammatory diseases and use thereof
DE60315827D1 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
ATE439441T1 (de) Veränderte, fluoreszierende proteine
BR9710919A (pt) Proteina purificada sr-p70
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
NO20024779D0 (no) G-protein-koblet reseptor
WO2002012541A3 (en) Novel motor proteins and methods for their use
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2001083524A3 (en) Rna metabolism proteins
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
EE200100234A (et) PRV-1-geen ja selle kasutamine
WO2004065554A3 (en) Human saa3 nucleic acid molecule, protein, and methods of use for same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition